Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. CDC Says Administered 407,446,961 Doses Of COVID-19 Vaccine As Of Oct 16

10/16/2021 | 03:35pm EST

Oct 16 (Reuters) - U.S. Centers for Disease Control and Prevention:

* U.S. CDC SAYS ADMINISTERED 407,446,961 DOSES OF COVID-19 VACCINE AS OF OCT 16 VERSUS 406,570,875 DOSES ADMINISTERED AS OF OCT 15

* U.S. CDC SAYS DELIVERED 494,918,755 DOSES OF COVID-19 VACCINE AS OF OCT 16 VERSUS 493,139,295 DOSES DELIVERED AS OF OCT 15

* U.S. CDC SAYS 218,562,924 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF OCT 16 VERSUS 218,318,056 INDIVIDUALS AS OF OCT 15

* U.S. CDC SAYS 188,902,483 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF OCT 16 VERSUS 188,655,196 INDIVIDUALS AS OF OCT 15

* U.S. CDC SAYS AS OF OCTOBER 16, 10,114,824 PEOPLE RECEIVED A BOOSTER DOSE FOR COVID-19 VACCINE SINCE AUGUST 13, 2021


ę Reuters 2021
All news about MODERNA, INC.
04:32pU.S. administers 473.2 mln doses of COVID-19 vaccines - CDC
RE
04:00pStudy suggests Pfizer COVID-19 vaccine may only partially protect against Omicron
RE
02:41pFlagship Pioneering taps former FDA chief Hahn to head new cancer diagnostic firm
RE
01:25pFauci says early evidence points to Omicron being more transmissible but less severe
RE
11:37aFlagship Pioneering taps former FDA chief Hahn to head new cancer diagnostic firm
RE
11:17aUp to 1 million COVID vaccines wasted in Nigeria last month
RE
11:16aUp to 1 million COVID vaccines wasted in Nigeria last month
RE
07:45aMarketScreener's World Press Review - December 7, 2021
07:16aEU agencies endorse mix-and-match of COVID-19 vaccines
RE
06:46aREFILE-EU health bodies recommend mix-and-match of COVID-19 vaccines
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 505 M - -
Net income 2021 11 217 M - -
Net cash 2021 12 344 M - -
P/E ratio 2021 10,7x
Yield 2021 -
Capitalization 114 B 114 B -
EV / Sales 2021 5,83x
EV / Sales 2022 4,41x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 282,35 $
Average target price 271,13 $
Spread / Average Target -3,98%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.170.27%107 578
LONZA GROUP AG25.98%56 683
IQVIA HOLDINGS INC.46.84%50 262
SEAGEN INC.-16.63%26 699
CELLTRION, INC.-43.31%23 888
ICON PUBLIC LIMITED COMPANY36.39%21 647